Keywords: Depakote, Divalproex, Abbott Laboratories, US Justice Department,
US Justice Department probing Abbott Lab’s Depakote marketing
Article | 09 November 2009
The US Justice Department is investigating Abbott Laboratories' sales and marketing activities for its anti-seizure drug Depakote (divalproex), its third ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
